Transcriptional complexity of the HSPG2 gene in the human mast cell line, HMC-1

Matrix Biology

Volumn 35, Issue , 2014, Pages 123-131

  Lord, Megan S ^a   Jung, MoonSun ^a   Cheng, Bill ^a   Whitelock, John M ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Alternative splicing; HSPG2; Mast cells; Perlecan

Indexed keywords

LAMININ; MESSENGER RNA; PERLECAN; VERY LATE ACTIVATION ANTIGEN 2; GLYCOSAMINOGLYCAN; PRIMER DNA; PROTEOHEPARAN SULFATE;

ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANGIOGENESIS; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; DNA BASE COMPOSITION; EXON; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HSPG2 GENE; HUMAN; HUMAN CELL; MAST CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; REAL TIME POLYMERASE CHAIN REACTION; RNA PROCESSING; SEQUENCE HOMOLOGY; ANALYSIS OF VARIANCE; BIOLOGICAL MODEL; CELL LINE; DNA SEQUENCE; ENDOTHELIUM CELL; GENETICS; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT;

MAMMALIA;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANALYSIS OF VARIANCE; BASE SEQUENCE; CELL LINE; DNA PRIMERS; ENDOTHELIAL CELLS; GLYCOSAMINOGLYCANS; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; INTEGRIN ALPHA2BETA1; MAST CELLS; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; NEOVASCULARIZATION, PHYSIOLOGIC; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION, GENETIC;

EID: 84901462642     PISSN: 0945053X     EISSN: 15691802     Source Type: Journal    
DOI: 10.1016/j.matbio.2013.12.005     Document Type: Article

References (49)

1. Arikawa-Hirasawa E., Yamada V. Perlecan mutations in mice and humans: Critical role of perlecan in skeletal development and disease. Acta Myol. 2001, 20:134-137.
2. Arikawa-Hirasawa E., Watanabe H., Takami H., et al. Perlecan is essential for cartilage and cephalic development. Nat. Genet. 1999, 23:354-358.
3. Arikawa-Hirasawa E., Le A.H., Nishino I., et al. Structural and functional mutations of the perlecan gene cause Schwartz-Jampel syndrome, with myotonic myopathy and chondrodysplasia. Am. J. Hum. Genet. 2002, 70:1368-1375.
4. Balasubramani M., Bier M.E., Hummel S., et al. Perlecan and its immunoglobulin like domain IV are abundant in vitreous and serum of the chick embryo. Matrix Biol. 2004, 23:143-152.
5. Bix G., Fu J., Gonzalez E.M., et al. Endorepellin causes endothelial cell disassembly of actin cytoskeleton and focal adhesions through α2β1 integrin. J. Cell Biol. 2004, 166:97-109.
6. Bix G., Iozzo R.A., Woodall B., et al. Endorepellin, the C-terminal angiostatic module of perlecan, enhances collagen-platelet responses via the α2β1-integrin receptor. Blood 2007, 109:3745-3748.
7. Brandenberger R., Wei H., Zhang S., et al. Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation. Nat. Biotechnol. 2004, 22:707-716.
8. Burset M., Seledtsov I.A., Solovyev V.V. Analysis of canonical and non-canonical splice sites in mammalian genomes. Nucleic Acids Res. 2000, 28:4364-4375.
9. Chakravarti S., Phillips S.L., Hassell J.R. Assignment of the perlecan (heparan sulfate proteoglycan) gene to mouse chromosome 4. Mamm. Genome 1991, 1:270-272.
10. Chuang C.Y., Lord M.S., Melrose J., et al. Heparan sulfate-dependent signaling of fibroblast growth factor 18 by chondrocyte-derived perlecan. Biochemistry 2010, 49:5524-5532.
11. Clarke D.N., Al Ahmad A., Lee B., et al. Perlecan Domain V Induces VEGf Secretion in Brain Endothelial Cells through Integrin α5β1 and ERK-Dependent Signaling Pathways. PLoS ONE 2012, 7:e45257.
12. Cohen I.R., Grassel S., Murdoch A.D., et al. Structural characterization of the complete human perlecan gene and its promoter. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:10404-10408.
13. Dias Neto E., Garcia Correa R., Verjovski-Almeida S., et al. Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:3491-3496.
14. Dodge G.R., Kovalszky I., Chu M.L., et al. Heparan sulfate proteoglycan of human colon: Partial molecular cloning, cellular expression, and mapping of the gene (HSPG2) to the short arm of human chromosome 1. Genomics 1991, 10:673-680.
15. Farach-Carson M.C., Warren C.R., Harrington D.A., et al. Border patrol: Insights into the unique role of perlecan/heparan sulfate proteoglycan 2 at cell and tissue borders. Matrix Biol 2013, 34:64-79.
16. Friedrich M.V.K., Göhring W., Mörgelin M., et al. Structural basis of glycosaminoglycan modification and of heterotypic interactions of perlecan domain V. J. Mol. Biol. 1999, 294:259-270.
17. Friedrich M.V.K., Schneider M., Timpl R., et al. Perlecan domain V of Drosophila melanogaster. Sequence, recombinant analysis and tissue expression. Eur. J. Biochem. 2000, 267:3149-3159.
18. Goyal A., Pal N., Concannon M., et al. Endorepellin, the angiostatic module of perlecan, interacts with both the α2β1 integrin and vascular endothelial growth factor receptor 2 (VEGFR2): A dual receptor antagonism. J. Biol. Chem. 2011, 286:25947-25962.
19. Hynes R.O. The evolution of metazoan extracellular matrix. J. Cell Biol. 2012, 196:671-679.
20. Iozzo R.V., Pillarisetti J., Sharma B., et al. Structural and functional characterization of the human perlecan gene promoter: Transcriptional activation by transforming growth factor-β via a nuclear factor 1-binding element. J. Biol. Chem. 1997, 272:5219-5228.
21. Jiang X., Couchman J.R. Perlecan and Tumor Angiogenesis. J. Histochem. Cytochem. 2003, 51:1393-1410.
22. Jung M., Lord M.S., Cheng B., et al. Mast cells produce novel shorter forms of perlecan that contain functional endorepellin a role in angiogenesis and wound healing. J. Biol. Chem. 2013, 288:3289-3304.
23. Kallunki P., Tryggvason K. Human basement membrane heparan sulfate proteoglycan core protein: A 467-kD protein containing multiple domains resembling elements of the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor. J. Cell Biol. 1992, 116:559-571.
24. Kallunki P., Eddy R.L., Byers M.G., et al. Cloning of human heparan sulfate proteoglycan core protein, assignment of the gene (HSPG2) to 1p36.1→p35 and identification of a bamHI restriction fragment length polymorphism. Genomics 1991, 11:389-396.
25. Kimura K., Wakamatsu A., Suzuki Y., et al. Diversification of transcriptional modulation: Large-scale identification and characterization of putative alternative promoters of human genes. Genome Res. 2006, 16:55-65.
26. Knox S., Merry C., Stringer S., et al. Not all perlecans are created equal. Interactions with fibroblast growth factor (FGF) 2 and FGF receptors. J. Biol. Chem. 2002, 277:14657-14665.
27. Laplante P., Raymond M.A., Labelle A., et al. Perlecan proteolysis induces an α2β1 integrin- and Src family kinase-dependent anti-apoptotic pathway in fibroblasts in the absence of focal adhesion kinase activation. J. Biol. Chem. 2006, 281:30383-30392.
28. Laveder P., De Pitta C., Toppo S., et al. A two-step strategy for constructing specifically self-subtracted cDNA libraries. Nucleic Acids Res. 2002, 30:E38.
29. Lee B., Clarke D., Al Ahmad A., et al. Perlecan domain V is neuroprotective and proangiogenic following ischemic stroke in rodents. J. Clin. Investig. 2011, 121:3005-3023.
30. Lord M.S., Cheng B., McCarthy S.J., et al. The modulation of platelet adhesion and activation by chitosan through plasma and extracellular matrix proteins. Biomaterials 2011, 32:6655-6662.
31. Lundquist E.A., Herman R.K. The mec-8 gene of Caenorhabditis elegans affects muscle and sensory neuron function and interacts with three other genes: unc-52, smu-1 and smu-2. Genetics 1994, 138:83-101.
32. Lundquist E.A., Herman R.K., Rogalski T.M., et al. The mec-8 gene of C. Elegans encodes a protein with two RNA recognition motifs and regulates alternative splicing of unc-52 transcripts. Development 1996, 122:1601-1610.
33. Melrose J., Roughley P., Knox S., et al. The structure, location, and function of perlecan, a prominent pericellular proteoglycan of fetal, postnatal, and mature hyaline cartilages. J. Biol. Chem. 2006, 281:36905-36914.
34. Mongiat M., Sweeney S.M., San Antonio J.D., et al. Endorepellin, a novel inhibitor of angiogenesis derived from the C-terminus of perlecan. J. Biol. Chem. 2003, 288:3289-3304.
35. Mullen G.P., Rogalski T.M., Bush J.A., et al. Complex patterns of alternative splicing mediate the spatial and temporal distribution of perlecan/UNC-52 in Caenorhabditis elegans. Mol. Biol. Cell 1999, 10:3205-3221.
36. Murdoch A.D., Dodge G.R., Cohen I., et al. Primary structure of the human heparan sulfate proteoglycan from basement membrane (HSPG2/perlecan). A chimeric molecule with multiple domains homologous to the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor. J. Biol. Chem. 1992, 267:8544-8557.
37. Nicole S., Vicart S., Davoine C.S., et al. Mutations of perlecan, the major proteoglycan of basement membranes, cause Schwartz-Jampel syndrome: A new mechanism for myotonia?. Acta Myol. 2001, 20:130-133.
38. Noonan D.M., Horigan E.A., Ledbetter S.R., et al. Identification of cDNA clones encoding different domains of the basement membrane heparan sulfate proteoglycan. J. Biol. Chem. 1988, 263:16379-16387.
39. Noonan D.M., Fulle A., Valente P., et al. The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipoprotein-receptor, and the neural cell adhesion molecule. J. Biol. Chem. 1991, 266:22939-22947.
40. Ota T., Suzuki Y., Nishikawa T., et al. Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat. Genet. 2004, 36:40-45.
41. Ozyildirim A.M., Wistow G.J., Gao J., et al. The lacrimal gland transcriptome is an unusually rich source of rare and poorly characterized gene transcripts. Invest. Ophthalmol. Vis. Sci. 2005, 46:1572-1580.
42. Rogalski T.M., Williams B.D., Mullen G.P., et al. Products of the unc-52 gene in Caenorhabditis elegans are homologous to the core protein of the mammalian basement membrane heparan sulfate proteoglycan. Genes Dev. 1993, 7:1471-1484.
43. Soulez M., Sirois I., Brassard N., et al. Epidermal growth factor and perlecan fragments produced by apoptotic endothelial cells co-ordinately activate ERK1/2-dependent antiapoptotic pathways in mesenchymal stem cells. Stem Cells 2010, 28:810-820.
44. Soulez M., Pilon E.A., Dieudé M., et al. The perlecan fragment LG3 is a novel regulator of obliterative remodeling associated with allograft vascular rejection. Circ. Res. 2012, 110:94-104.
45. Spartz A.K., Herman R.K., Shaw J.E. SMU-2 and SMU-1, Caenorhabditis elegans homologs of mammalian spliceosome-associated proteins RED and fSAP57, work together to affect splice site choice. Mol. Cell. Biol. 2004, 24:6811-6823.
46. Spike C.A., Shaw J.E., Herman R.K. Analysis of smu-1, a gene that regulates the alternative splicing of unc-52 pre-mRNA in Caenorhabditis elegans. Mol. Cell. Biol. 2001, 21:4985-4995.
47. Tapanadechopone P., Hassell J.R., Rigatti B., et al. Localization of glycosaminoglycan substitution sites on domain V of mouse perlecan. Biochem. Biophys. Res. Commun. 1999, 265:680-690.
48. Whitelock J.M., Murdoch A.D., Iozzo R.V., et al. The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases. J. Biol. Chem. 1996, 271:10079-10086.
49. Woodall B.P., Nyström A., Iozzo R.A., et al. Integrin α2β1 is the required receptor for endorepellin angiostatic activity. J. Biol. Chem. 2008, 283:2335-2343.